Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

4 Résultats
Auteur : personID (entier) : 766590

Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab

Julien Taieb , Aziz Zaanan , Karine Le Malicot , Catherine Julié , Hélène Blons et al.
JAMA oncology, 2016, 2 (5), ⟨10.1001/jamaoncol.2015.5225⟩
Article dans une revue hal-01427989v1

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

Thierry André , Dewi Vernerey , Laurent Mineur , Jaafar Bennouna , Jérôme Desramé et al.
Journal of Clinical Oncology, 2018, 36 (15), pp.1469-1477. ⟨10.1200/JCO.2017.76.0355⟩
Article dans une revue hal-01951156v1

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

Simon Pernot , Cecile Badoual , Magali Terme , Florence Castan , Aurelie Cazes et al.
European Journal of Cancer, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
Article dans une revue hal-01579145v1
Image document

Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)

Thomas Aparicio , Francois Ghiringhelli , Valérie Boige , Karine Le Malicot , Julien Taieb et al.
Journal of Clinical Oncology, 2018, 36 (7), pp.674 - 681. ⟨10.1200/JCO.2017.75.2931⟩
Article dans une revue hal-01728824v1